Financial Summary (All financials)
| In millions, except per share items | Dec-31-12 | Dec-31-11 | Dec-31-10 |
| Revenues | 0.2 | 4.0 | 44.1 |
| Revenue growth | -95.0% | -90.9% | |
| Cost of goods sold | 0.2 | 0.8 | 12.2 |
| Gross profit | 0.0 | 3.2 | 31.9 |
| Gross margin | 0.0% | 80.0% | 72.3% |
| Selling, general and administrative | 113.6 | 107.2 | 124.2 |
| Research and development | 95.0 | 106.8 | 128.5 |
| EBITA | -122.1 | -137.8 | -213.2 |
| EBITA margin | -61050.0% | -3445.0% | -483.4% |
| Amortization of intangibles | 14.6 | 15.9 | 28.4 |
| EBIT | -136.7 | -153.7 | -241.6 |
| EBIT margin | -68350.0% | -3842.5% | -547.8% |
| Pre-tax income | -733.2 | -465.5 | -613.5 |
| Income taxes | -360.5 | -12.0 | -52.2 |
| Tax rate | 49.2% | 2.6% | 8.5% |
| Earnings from continuing ops | -372.7 | -453.5 | -561.3 |
| Earnings from discontinued ops | 235.3 | 1,014.0 | 236.6 |
| Net income | -137.4 | 560.5 | -324.7 |
| Net margin | -68700.0% | 14012.5% | -736.3% |
| |
| Diluted EPS | ($0.63) | ($0.77) | ($0.96) |
| Shares outstanding (diluted) | 592.4 | 587.6 | 584.9 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|